Announcement of TTY Biopharm's unaudited income information in July 2021
2021.8.11
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/08/11 | Time of announcement | 15:41:38 |
| Subject | Announcement of TTY Biopharm's unaudited income information in July 2021 | ||||
| Date of events | 2021/08/11 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2021/08/11 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $338,674 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $83,471 thousands, and a consolidated income before tax of $88,920 thousands in July 2021; net income attributed to stockholders of the parent company was $71,082 thousands; EPS is $0.29. Year-to-date consolidated net sales was $2,345,903 thousands (in NT dollars; unaudited), a consolidated operating profit was $354,689 thousands and consolidated income before tax was $436,578 thousands until July 2021; year-to-date net income attributed to stockholders of the company was $306,104 thousands; EPS is $1.23. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||